Why Iovance Biotherapeutics Stock Stumbled Today
Iovance Biotherapeutics(IOVA) The Motley Fool·2024-07-29 22:24No investor likes it when one of their stocks is hit with a recommendation downgrade from an analyst. That was the dynamic behind Iovance Biotherapeutics' (IOVA -2.16%) more than 2% decline in value on Monday. A onetime Iovance bull has considerably cooled on the stock, and this triggered a bit of a sell-off for the biotech. Biotech blues In his research note detailing the change, Catanzaro cited field research on the biotech's first commercialized drug, Amtagvi. He found that, "Despite a solid number of pa ...